Upon completion of the module, the participant will:
Schedule:
Hyperbaric Oxygen Therapies | Mark Rosenberg, MD |
Antineoplastons, Chemistry, Mechanism of Action, Design, and Criticism of Clinical Trials | Stanislaw R. Burzynski, MD, PhD |
Prospective Clinical Trials with Antineoplastons for Inoperable Brain Tumors in Children | Stanislaw R. Burzynski, MD, PhD |
Phase 2 Prospective Clinical Trials for Inoperable Brain Tumors in Adults | Stanislaw R. Burzynski, MD, PhD |
Vitamin C and Cancer- History and The Next Generation | Michael Gonzalez, PhD |
Vitamin C and Cancer – The Scientific Basis for the use of Ascorbic Acid in Cancer | Michael Gonzalez, PhD |
Vitamin C and Cancer – The RECNAC Protocol | Michael Gonzalez, PhD |
Vitamin C and Cancer – The Systemic Saturation Concept and the Bioenergetic Theory of Carcinogenesis | Michael Gonzalez, PhD |
Mind Body Medicine in Cancer Patients | Ines Alfaro, MD |
Mind Body Medicine in Cancer Patients (Continued) | Ines Alfaro, MD |
Evaluating the Evidence of Controversial Cancer Treatments | Dwight McKee, MD |
Using Oxidative Therapies in a Cancer Management Protocol | Frank Shallenberger, MD |
Using Oxidative Therapies in a Cancer Management Protocol | Frank Shallenberger, MD |
Obesity, Exercise and Cancer Prevention | Pallav Mehta, MD |
Exercise During and After Cancer Treatment | Pallav Mehta, MD |
Cocktails Off-Label Drugs in Cancer Treatment Part II | Dwight McKee, MD |
TK 1 and Cancer: A Novel Tumor Marker | Mark Rosenberg, MD |
Gateby and Adaptive Therapy | Mark Rosenberg, MD |